Design, synthesis, and evaluation of novel 4-thiazolylimidazoles as inhibitors of transforming growth factor-β type I receptor kinase-Reference-Cited by-同舟云学术

Design, synthesis, and evaluation of novel 4-thiazolylimidazoles as inhibitors of transforming growth factor-β type I receptor kinase

Published:2012-03 Issue:5 Volume:22 Page:2024-2029
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Amada Hideaki,Sekiguchi Yoshinori,Ono Naoya,Matsunaga Yuko,Koami Takeshi,Asanuma Hajime,Shiozawa Fumiyasu,Endo Mayumi,Ikeda Akiko,Aoki Mari,Fujimoto Natsuko,Wada Reiko,Sato Masakazu

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference16 articles.

1. TGF-β signalling from cell membrane to nucleus through SMAD proteins

2. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus

3. Development of TGF-β signalling inhibitors for cancer therapy

4. TGF‐β signaling and the fibrotic response

5. Transforming Growth Factor-β, Cell Signaling and Cardiovascular Disorders

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors;Bioorganic Chemistry;2024-06

2. Small-molecule modulators of tumor immune microenvironment;Bioorganic Chemistry;2024-04

3. Synthesis and preclinical evaluation of [11C]LR111 and [18F]EW-7197 as PET tracers of the activin-receptor like kinase-5;Nuclear Medicine and Biology;2022-09

4. Synthesis and Evaluation of Chiral Rhodanine Derivatives Bearing Quinoxalinyl Imidazole Moiety as ALK5 Inhibitors;Medicinal Chemistry;2022-04

5. Recent development of imidazole derivatives as potential anticancer agents;Physical Sciences Reviews;2022-01-13